Quantcast

Latest Venous ulcer Stories

2014-09-17 16:26:41

VLU STUDY PATIENTS TREATED WITH EPIFIX® ALLOGRAFT HAD DOUBLE THE RATE OF WOUND CLOSURE COMPARED TO CONTROL GROUP MARIETTA, Ga., Sept. 17, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today the publication of another peer-reviewed clinical study. The study article, "A Multi-center Randomized Controlled Clinical Trial...

2014-08-04 08:27:45

Access to Apligraf® is Improved for Veterans with Chronic Diabetic Foot Ulcers and Venous Leg Ulcers CANTON, Mass., Aug 4, 2014 /PRNewswire/ -- Organogenesis Inc. announced today that it has been awarded Federal Supply Schedule Contract V797D-30288 with the Department of Veterans Affairs (VA) for Apligraf®, the only product with FDA approval for the treatment of both diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). This five-year contract includes an option to extend its...

2014-06-16 12:29:29

REHOVOT, Israel, June 16, 2014 /PRNewswire/ -- CollPlant (TASE: CLPT), developer and manufacturer of human collagen-based medical products announces that it has received approval from the Israeli Ministry of Health to carry out clinical trial with its Flowable Gel, an advanced and innovative product for the treatment of wounds. CollPlant plans to start the trial in the coming weeks. For the conduction of the trial, CollPlant will cooperate with the Maccabi HMO, and the...

2014-04-29 23:06:04

Experienced biomaterials professional to lead company in development of new treatments for difficult to heal, chronic wounds using proprietary silk technology. Waltham, MA (PRWEB) April 29, 2014 Akeso Biomedical, Inc., a privately held medical device company developing innovative wound healing products for the treatment of chronic skin ulcers, announced that it has appointed Simon F. Williams, Ph.D. as Chief Executive Officer. Dr. Williams, a former CEO of a tissue engineering company and...

2014-04-23 12:29:55

EpiFix® is shown to promote rapid healing and return to function for patients and provide a potential for significant cost savings. MARIETTA, Ga., April 23, 2014 /PRNewswire/ -- EpiFix®, dehydrated human amnion/chorion membrane (dHACM) allografts, were shown to be clinically and cost effective in the treatment of multiple hard-to-treat wounds like diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers (PUs), according to data and case experiences being presented at the...

2014-04-22 12:31:27

CANTON, Mass. and ORLANDO, Fla., April 22, 2014 /PRNewswire/ -- This week, Organogenesis Inc. will present new mechanisms of action data from an Apligraf(®) clinical study and in vitro / pre-clinical data evaluating mechanisms of healing for Dermagraft(®) at the Symposium on Advanced Wound Care (SAWC) / Wound Healing Society (WHS) Spring 2014 meeting in Orlando, Fla. Additionally, Organogenesis will feature both Apligraf and Dermagraft at booth #709. "There is more than a decade of...

2014-04-07 08:30:21

ADDISON, Texas, April 7, 2014 /PRNewswire/ --ULURU Inc. (OTCQB: ULUR), is pleased to provide an update on the pharmacoeconomic analysis being conducted in Europe on Altrazeal(®), the Company's innovative wound dressing. The purpose of this pharmacoeconomic analysis is to evaluate both the cost and healing benefits of Altrazeal(®) when compared to conventional dressings and advanced moist wound healing products. The analysis is being conducted on defined-wound types and sizes,...

2014-03-27 12:31:18

VIRGINIA BEACH, Va., March 27, 2014 /PRNewswire-USNewswire/ -- Recent healthcare coverage decisions could offer relief to the nearly twelve million Medicare-eligible Seniors across 15 States, based on estimates from the Centers for Medicare & Medicaid. Senior citizens with diabetes are at risk to develop diabetic foot ulcers and venous leg ulcers - hard-to-heal wounds that are involved in nearly two-thirds of all non-traumatic lower limb amputations each year. Novitas, a Part A...

2014-02-23 23:00:50

Transparency Market Research Report added "Global Negative Pressure Wound Therapy Market - Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/negative-pressure-wound-therapy.html. Albany, New York, USA (PRWEB) February 23, 2014 Negative Pressure Wound Therapy (NPWT) also known as Vacuum Assisted Closure (V.A.C) is a wound dressing technique that aids in healing acute and chronic...

2014-02-06 23:02:45

Journey below the skin's surface for a better understanding of leg health and venous disorders with SIGVARIS’ new educational app for iPad. Peachtree City, GA (PRWEB) February 06, 2014 Physicians who advise patients about their leg health now have a new tool at their fingertips. SIGVARIS’ new app goes beneath the skin's surface to help explain the circulatory system and leg health conditions to patients in an illustrative way that is easy to understand. Traveling deep into...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.